Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
(NASDAQ: LIVN) Delayed: 79.39 -0.55 (0.69%)
Previous Close $79.94    52 Week High $63.21 
Open $79.66    52 Week Low $41.17 
Day High $80.02    P/E N/A 
Day Low $78.56    EPS $0.00 
Volume 725,970